sn201204166k.htm
 
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
 
 
Report of Foreign Private Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of

1934
 
 
April 16, 2012
 
Commission File Number 001-14978


SMITH & NEPHEW plc
(Registrant's name)


15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)

 
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]

 
Form 20-F X                Form 40-F
    ---                               ---

[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]


Yes                        No X
---                         ---

 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]

 
Yes                      No X
---                         ---

[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]

 
Yes                  No X
---                   ---

 
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.





 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Smith & Nephew Plc
(Registrant)
 
 
Date: April 16, 2012
 
 
By: /s/ Susan Henderson
-----------------
Susan Henderson
Company Secretary
 
 
 
 

 

Timing of Smith & Nephew first quarter results
 
16 April 2012
 
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the first quarter ended 31 March 2012 on Thursday 3 May 2012 at 7.00am GMT/2.00am Eastern time.  This will be followed by a conference call for financial analysts at 8.30am GMT/3.30am Eastern time, which can be heard live via audio webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
 
About Us
 
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives.  With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies, Smith & Nephew has almost 11,000 employees and a presence in more than 90 countries. Sales in 2011 were nearly $4.3 billion.  Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
 
 
Enquiries:
 
 
Investors/Analysts
 
Kim Gunthorp
Tel: +44 (0) 207 401 7646
Smith & Nephew plc
 
   
Media
 
Charles Reynolds
Smith & Nephew plc
 
Justine McIlroy
Brunswick - London
Tel: +44 (0) 207 401 7646
 
 
Tel: +44 (0) 207 404 5959